This information was published on 2025-04-27T00:09:13 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2501962 |
| (220) |
26 Nov 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing’s syndrome and Cushing’s disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders |
| (540) | RELMARQA |
| (550) | Word |
| (730) |
Corcept Therapeutics Incorporated
|
| (750) |
Allens Patent & Trade Mark Attorneys
|
Find out more about publications on the About page.